moclobemide has been researched along with Shock in 1 studies
Moclobemide: A reversible inhibitor of monoamine oxidase type A; (RIMA); (see MONOAMINE OXIDASE INHIBITORS) that has antidepressive properties.
moclobemide : A member of the class of benzamides that is benzamide substituted by a chloro group at position 4 and a 2-(morpholin-4-yl)ethyl group at the nitrogen atom. It acts as a reversible monoamine oxidase inhibitor and is used in the treatment of depression.
Shock: A pathological condition manifested by failure to perfuse or oxygenate vital organs.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Two cases of poisoning with moclobemide are presented." | 3.69 | [Poisoning with a reversible and selective monoaminooxidase inhibitor]. ( Bested, KM; Eriksen, ND; Pall, M, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Pall, M | 1 |
| Bested, KM | 1 |
| Eriksen, ND | 1 |
1 other study available for moclobemide and Shock
| Article | Year |
|---|---|
[Poisoning with a reversible and selective monoaminooxidase inhibitor].
Topics: Adult; Antidepressive Agents; Benzamides; Critical Care; Drug Overdose; Female; Humans; Moclobemide; | 1997 |